Citizens Business Bank’s GSK GSK Stock Holding History

Citizens Business Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,000	Closed	-$281K	–	112
2022 Q4	$281K	Hold	8,000	–	–	0.06%	105
2022 Q3	$235K	Hold	8,000	–	–	0.06%	103
2022 Q2	$435K	Hold	8,000	–	–	0.06%	198
2022 Q1	$436K	Hold	8,000	–	–	0.05%	202
2021 Q4	$441K	Hold	8,000	–	–	0.05%	208
2021 Q3	$382K	Hold	8,000	–	–	0.05%	209
2021 Q2	$398K	Hold	8,000	–	–	0.05%	214
2021 Q1	$357K	Hold	8,000	–	–	0.05%	214
2020 Q4	$368K	Hold	8,000	–	–	0.05%	204
2020 Q3	$376K	Hold	8,000	–	–	0.06%	189
2020 Q2	$408K	Hold	8,000	–	–	0.07%	185
2020 Q1	$379K	Hold	8,000	–	–	0.08%	188
2019 Q4	$470K	Sell	8,000 -137	-2%	-$7.62K	0.08%	191
2019 Q3	$434K	Hold	8,137	–	–	0.07%	205
2019 Q2	$407K	Buy	8,137 +137	+2%	+$6.87K	0.07%	212
2019 Q1	$418K	Hold	8,000	–	–	0.07%	210
2018 Q4	$382K	Sell	8,000 -320	-4%	-$15.8K	0.07%	212
2018 Q3	$418K	Hold	8,320	–	–	0.07%	228
2018 Q2	$419K	Hold	8,320	–	–	0.07%	223
2018 Q1	$407K	Hold	8,320	–	–	0.07%	221
2017 Q4	$369K	Hold	8,320	–	–	0.06%	234
2017 Q3	$422K	Hold	8,320	–	–	0.07%	222
2017 Q2	$448K	Hold	8,320	–	–	0.07%	222
2017 Q1	$439K	Hold	8,320	–	–	0.07%	219
2016 Q4	$400K	Buy	+8,320	New	+$411K	0.07%	223

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citizens Business Bank's GSK Position: Q1 2023 in Review

Citizens Business Bank sold out of GSK (GSK) in Q1 2023, closing a stake of 8,000 shares — an estimated $281K sold.

Citizens Business Bank first reported a position in GSK in Q4 2016 and held it in 25 quarters. The position peaked at $470K in Q4 2019. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Citizens Business Bank reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Citizens Business Bank sold 8,000 GSK shares in Q1 2023, an estimated $281K.
Citizens Business Bank first reported a position in GSK in Q4 2016 and held it in 25 quarters.
Citizens Business Bank's GSK position peaked at $470K in Q4 2019.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Citizens Business Bank's 13F filing for Q1 2023, filed 9 May 2023.